Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The ODP | ODP | Aug 30, 2024 | 30.85 | +2.49 |
The OLB Group | OLB | Aug 30, 2024 | 2.37 | +2.31 |
The Oncology Institute | TOI | Aug 30, 2024 | 0.36 | -5.44 |
The ONE Group Hospitality | STKS | Aug 30, 2024 | 3.85 | -1.53 |
The Pennant Group | PNTG | Aug 30, 2024 | 34.26 | +3.35 |
The Real Brokerage | REAX | Aug 30, 2024 | 6.23 | -1.89 |
The Real Estate Select Sector SPDR Fund | XLRE | Aug 30, 2024 | 43.55 | +0.97 |
The RealReal | REAL | Aug 30, 2024 | 2.64 | +0.38 |
The RMR Group A | RMR | Aug 30, 2024 | 25.49 | +0.75 |
The Shyft Group | SHYF | Aug 30, 2024 | 14.19 | +0.35 |
The Trade Desk A | TTD | Aug 30, 2024 | 104.53 | +0.99 |
The9 ADR | NCTY | Aug 30, 2024 | 7.10 | -1.25 |
TherapeuticsMD | TXMD | Aug 30, 2024 | 1.89 | +0.27 |
Theratechnologies | THTX | Aug 30, 2024 | 1.28 | 0.00 |
Theravance Biopharma | TBPH | Aug 30, 2024 | 8.25 | +0.49 |
Theriva Biologics | TOVX | Aug 30, 2024 | 5.90 | +25.53 |
Thermo Fisher Scientific | TMO | Aug 30, 2024 | 615.07 | +0.55 |
Thermon Group | THR | Aug 30, 2024 | 31.43 | +1.68 |
Third Coast Bancshares | TCBX | Aug 30, 2024 | 25.61 | +1.23 |
Third Harmonic | THRD | Aug 30, 2024 | 11.55 | -1.70 |
Thomson Reuters | TRI | Aug 30, 2024 | 171.18 | +0.95 |
Thor Industries | THO | Aug 30, 2024 | 107.26 | +0.76 |
Thornburg Income Builder Opportunities Fund | TBLD | Aug 30, 2024 | 17.10 | +0.18 |
Thoughtworks | TWKS | Aug 30, 2024 | 4.35 | +0.23 |
ThredUp A | TDUP | Aug 30, 2024 | 0.91 | +0.12 |
Thryv | THRY | Aug 30, 2024 | 18.22 | -2.25 |
Thunder Bridge Capital Partners IV SPAC A | THCP | Aug 30, 2024 | 10.49 | 0.00 |
Thunder Power | AIEV | Aug 30, 2024 | 0.64 | 0.00 |
Tian Ruixiang A | TIRX | Aug 30, 2024 | 1.73 | -1.14 |
Tidewater | TDW | Aug 30, 2024 | 88.70 | +0.44 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.